Search Results - "Cochran, J Nicholas"
-
1
Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease
Published in Journal of cell science (01-03-2013)“…Normally post-mitotic neurons that aberrantly re-enter the cell cycle without dividing account for a substantial fraction of the neurons that die in…”
Get full text
Journal Article -
2
Reduced PIN1 expression in neocortical and limbic brain regions in female Alzheimer’s patients correlates with cognitive and neuropathological phenotypes
Published in Neurobiology of aging (01-09-2024)“…Women have a higher incidence of Alzheimer’s disease (AD), even after adjusting for increased longevity. Thus, there is an urgent need to identify genes that…”
Get full text
Journal Article -
3
The dendritic hypothesis for Alzheimer's disease pathophysiology
Published in Brain research bulletin (01-04-2014)“…Highlights • Dendritic neuropathology is ubiquitous in Alzheimer's Disease (AD). • Aβ causes dendritic neuropathology in AD. • Dendritic mislocalization of Tau…”
Get full text
Journal Article -
4
Genomic diagnosis for children with intellectual disability and/or developmental delay
Published in Genome medicine (30-05-2017)“…Developmental disabilities have diverse genetic causes that must be identified to facilitate precise diagnoses. We describe genomic data from 371 affected…”
Get full text
Journal Article -
5
A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity
Published in Neurobiology of disease (01-02-2020)“…The microtubule-associated protein Tau is strongly implicated in Alzheimer's disease (AD) and aggregates into neurofibrillary tangles in AD. Genetic reduction…”
Get full text
Journal Article -
6
The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science
Published in Frontiers in neurology (11-03-2021)“…Dementia is becoming increasingly prevalent in Latin America, contrasting with stable or declining rates in North America and Europe. This scenario places…”
Get full text
Journal Article -
7
Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy
Published in PLoS genetics (07-01-2021)“…Dravet syndrome (DS) is a developmental and epileptic encephalopathy that results from mutations in the Nav1.1 sodium channel encoded by SCN1A. Most known…”
Get full text
Journal Article -
8
Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability
Published in eLife (13-07-2020)“…Genome-wide association studies identified the locus as a leading modulator of genetic risk in Alzheimer's disease (AD). One limitation in understanding 's…”
Get full text
Journal Article -
9
PEA15 loss of function and defective cerebral development in the domestic cat
Published in PLoS genetics (01-12-2020)“…Cerebral cortical size and organization are critical features of neurodevelopment and human evolution, for which genetic investigation in model organisms can…”
Get full text
Journal Article -
10
A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects
Published in Genome medicine (08-03-2022)“…The Colombian population, as well as those in other Latin American regions, arose from a recent tri-continental admixture among Native Americans, Spanish…”
Get full text
Journal Article -
11
Therapeutic Response in Feline Sandhoff Disease Despite Immunity to Intracranial Gene Therapy
Published in Molecular therapy (01-07-2013)“…Salutary responses to adeno-associated viral (AAV) gene therapy have been reported in the mouse model of Sandhoff disease (SD), a neurodegenerative lysosomal…”
Get full text
Journal Article -
12
Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
Published in Alzheimer's & dementia : diagnosis, assessment & disease monitoring (01-10-2023)“…Early‐onset Alzheimer's disease (AD) is highly heritable, yet only 10% of cases are associated with known pathogenic mutations. For early‐onset AD patients…”
Get full text
Journal Article -
13
APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease
Published in The New England journal of medicine (31-10-2024)“…To the Editor: The report by Quiroz et al. (June 20 issue) 1 on the Colombian PSEN1 E280A pedigree suggests a protective effect of apolipoprotein E3…”
Get full text
Journal Article -
14
The Alzheimer's disease risk factor CD2AP maintains blood-brain barrier integrity
Published in Human molecular genetics (01-12-2015)“…CD2-associated protein (CD2AP) is a leading genetic risk factor for Alzheimer's disease, but little is known about the function of CD2AP in the brain. We…”
Get full text
Journal Article -
15
Response to Holstege et al
Published in American journal of human genetics (03-09-2020)Get full text
Journal Article -
16
Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies
Published in American journal of human genetics (06-12-2018)“…Developmental and epileptic encephalopathies (DEEs) are a group of severe epilepsies characterized by refractory seizures and developmental impairment…”
Get full text
Journal Article -
17
Non-coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases
Published in American journal of human genetics (07-05-2020)“…We conducted genome sequencing to search for rare variation contributing to early-onset Alzheimer’s disease (EOAD) and frontotemporal dementia (FTD). Discovery…”
Get full text
Journal Article -
18
Neuronal MAPT expression is mediated by long-range interactions with cis-regulatory elements
Published in American journal of human genetics (01-02-2024)“…Tauopathies are a group of neurodegenerative diseases defined by abnormal aggregates of tau, a microtubule-associated protein encoded by MAPT. MAPT expression…”
Get full text
Journal Article -
19
Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability
Published in Neurotherapeutics (01-01-2024)“…Alzheimer's disease (AD) is the leading cause of dementia and lacks highly effective treatments. Tau-based therapies hold promise. Tau reduction prevents…”
Get full text
Journal Article -
20
Life‐Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy
Published in Annals of neurology (01-11-2023)“…Objective GM2 gangliosidosis is usually fatal by 5 years of age in its 2 major subtypes, Tay‐Sachs and Sandhoff disease. First reported in 1881, GM2…”
Get full text
Journal Article